AAMU
MJN

Amundi Asset Management US’s Mead Johnson Nutrition Company MJN Stock Holding History

Amundi Asset Management US’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-303,401
Closed -$21.5M – 566
2016
Q4 		$21.5M Sell
303,401
-12,302
-4% -$917K 0.08% 201
2016
Q3 		$24.9M Sell
315,703
-269,620
-46% -$23M 0.09% 190
2016
Q2 		$53.1M Sell
585,323
-4,136
-0.7% -$350K 0.19% 104
2016
Q1 		$50.1M Sell
589,459
-498,635
-46% -$37.1M 0.19% 111
2015
Q4 		$85.9M Buy
1,088,094
+147,393
+16% +$11.6M 0.32% 83
2015
Q3 		$66.2M Buy
940,701
+147,606
+19% +$12.1M 0.27% 103
2015
Q2 		$71.6M Buy
793,095
+73,277
+10% +$7.07M 0.26% 107
2015
Q1 		$72.4M Buy
719,818
+1,949
+0.3% +$197K 0.26% 103
2014
Q4 		$72.2M Buy
717,869
+45,699
+7% +$4.55M 0.26% 109
2014
Q3 		$64.7M Sell
672,170
-3,009
-0.4% -$285K 0.24% 120
2014
Q2 		$62.9M Buy
675,179
+207,836
+44% +$18.2M 0.24% 118
2014
Q1 		$38.9M Buy
+467,343
New +$37.9M 0.15% 173

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amundi Asset Management US's MJN Position: Q1 2017 in Review

Amundi Asset Management US sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 303,401 shares — an estimated $21.5M sold.

Amundi Asset Management US first reported a position in MJN in Q1 2014 and held it in 12 quarters. The position peaked at $85.9M in Q4 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Amundi Asset Management US reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Amundi Asset Management US sold 303,401 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $21.5M.
  • Amundi Asset Management US first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 12 quarters.
  • Amundi Asset Management US's Mead Johnson Nutrition Company position peaked at $85.9M in Q4 2015.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Amundi Asset Management US's 13F filing for Q1 2017, filed 8 May 2017.